Cationic liposomes as promising vehicles for timolol/brimonidine combination ocular delivery in glaucoma: formulation development and in vitro/in vivo evaluation-Reference-Cited by-同舟云学术

Cationic liposomes as promising vehicles for timolol/brimonidine combination ocular delivery in glaucoma: formulation development and in vitro/in vivo evaluation

Published:2022-12-07 Issue:4 Volume:13 Page:1035-1047
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

bigdeli Ali,Makhmalzadeh Behzad Sharif^ORCID,Feghhi Mostafa,SoleimaniBiatiani Emad

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s13346-022-01266-8.pdf

Reference61 articles.

1. Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma. JAMA. 2014;311(18):1901–1911.

2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Omlthalmol. 2006;90:262–7.

3. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–90.

4. Gan L, Wang J, Jiang M, Bartlett H, Ouyang D, Eperjesi F, et al. Recent advance in topical ophthalmic drug delivery with lipid-based Nano carriers. Drug Discov Today. 2013;18(5–6):290–7.

5. Del Amo EM, Urtti A. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov Today. 2008;13:135–143.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine in glaucoma treatment; Current challenges and future perspectives;Materials Today Bio;2024-10

2. Drug Delivery Systems for Glaucoma: A Narrative Review;Pharmaceuticals;2024-09-02

3. Chitosan/carbomer nanoparticles- laden in situ gel for improved ocular delivery of timolol: in vitro, in vivo, and ex vivo study;Drug Delivery and Translational Research;2024-07-08

4. Research progress of nano delivery systems for intraocular pressure lowering drugs;Heliyon;2024-06

5. In vivo biodistribution and ototoxicity assessment of cationic liposomal-ceftriaxone via noninvasive trans-tympanic delivery in chinchilla models: Implications for otitis media therapy;International Journal of Pediatric Otorhinolaryngology;2024-03